Westend Capital Management’s Celgene Corp CELG Stock Holding History

Westend Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.38M	Hold	13,233	–	–	1.93%	27
2016 Q2	$1.3M	Sell	13,233 -157	-1%	-$16.2K	1.89%	25
2016 Q1	$1.34M	Sell	13,390 -9,750	-42%	-$1M	1.83%	24
2015 Q4	$2.77M	Buy	23,140 +915	+4%	+$106K	3.8%	7
2015 Q3	$2.62M	Buy	22,225 +2,259	+11%	+$280K	3.33%	7
2015 Q2	$2.33M	Buy	19,966 +111	+0.6%	+$12.7K	2.72%	10
2015 Q1	$2.29M	Sell	19,855 -2,465	-11%	-$295K	2.71%	11
2014 Q4	$2.5M	Sell	22,320 -3,561	-14%	-$376K	2.88%	8
2014 Q3	$2.28M	Buy	25,881 +3,567	+16%	+$322K	2.49%	18
2014 Q2	$1.9M	Sell	22,314 -468	-2%	-$35.6K	2.27%	18
2014 Q1	$1.57M	Buy	22,782 +11,694	+105%	+$926K	1.87%	27
2013 Q4	$937K	Buy	+11,088	New	+$877K	1.01%	34

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westend Capital Management's CELG Position: Q3 2016 in Review

Westend Capital Management held its Celgene Corp (CELG) position steady in Q3 2016 at 13,233 shares worth $1.38M. The position accounts for 1.93% of the portfolio, ranked #27.

Westend Capital Management first reported a position in CELG in Q4 2013 and has held it in 12 quarters since. The position peaked at $2.77M in Q4 2015. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

Westend Capital Management held 13,233 shares of Celgene Corp worth $1.38M as of Q3 2016.
Westend Capital Management left its Celgene Corp share count unchanged in Q3 2016.
Celgene Corp made up 1.93% of Westend Capital Management's portfolio in Q3 2016, its #27 holding.
Westend Capital Management first reported a position in Celgene Corp in Q4 2013 and has held it in 12 quarters since.
Westend Capital Management's Celgene Corp position peaked at $2.77M in Q4 2015.
1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Westend Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.